Capital Investment Advisors LLC Grows Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Capital Investment Advisors LLC grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 899 shares of the medical equipment provider’s stock after purchasing an additional 121 shares during the quarter. Capital Investment Advisors LLC’s holdings in Intuitive Surgical were worth $469,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Mirador Capital Partners LP lifted its stake in Intuitive Surgical by 1.4% in the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after purchasing an additional 50 shares in the last quarter. Exome Asset Management LLC raised its position in shares of Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after buying an additional 1,069 shares during the period. Consolidated Planning Corp raised its position in shares of Intuitive Surgical by 17.4% during the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after buying an additional 1,198 shares during the period. Wealth Enhancement Advisory Services LLC raised its position in shares of Intuitive Surgical by 73.2% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 270,029 shares of the medical equipment provider’s stock valued at $132,657,000 after buying an additional 114,149 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund raised its position in shares of Intuitive Surgical by 617.1% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock valued at $39,622,000 after buying an additional 76,649 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Up 7.7 %

NASDAQ:ISRG opened at $580.11 on Thursday. The company has a fifty day simple moving average of $537.05 and a two-hundred day simple moving average of $496.50. The company has a market cap of $206.62 billion, a price-to-earnings ratio of 93.27, a price-to-earnings-growth ratio of 5.31 and a beta of 1.39. Intuitive Surgical, Inc. has a 52 week low of $355.17 and a 52 week high of $584.60.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Analyst Ratings Changes

Several analysts have recently commented on ISRG shares. JPMorgan Chase & Co. lifted their price target on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Evercore ISI reaffirmed a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. BTIG Research lifted their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Truist Financial lifted their price target on shares of Intuitive Surgical from $570.00 to $640.00 and gave the company a “buy” rating in a research report on Wednesday, December 18th. Finally, Wells Fargo & Company lifted their target price on shares of Intuitive Surgical from $549.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, December 11th. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $554.17.

Insiders Place Their Bets

In related news, CFO Jamie Samath sold 270 shares of the business’s stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the completion of the transaction, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,730,093.55. The trade was a 2.99 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Brian Edward Miller sold 2,553 shares of the business’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the transaction, the executive vice president now owns 7,066 shares of the company’s stock, valued at approximately $3,638,990. The trade was a 26.54 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 48,190 shares of company stock worth $25,012,927 over the last 90 days. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.